Manuel Sureda González
- 4.3 良い • 4 レビュー
- 76年の経験
- スペイン, アリカンテ, Quironsalud Torrevieja
Education and Training
Doctor of Medicine, Cum Laude, University of Navarra (1991)
Medical Degree, University of Navarra (1979–1985), Graduated with Honors
Board-Certified Specialist in Medical Oncology, via Spanish MIR system, Clínica Universidad de Navarra (1986–1989)
Advanced Fellowship in Immunotherapy, Cleveland Clinic Foundation, USA
Professional Experience
Head of Medical Oncology (1993–2000) and Director of the Cancer Institute (2000–2002), General Hospital of Catalonia
Director of Hematopoietic Progenitor Transplant Program, General Hospital of Catalonia (1993–2002), accredited by the Catalonian Health Department
Senior Specialist in Oncology, Quirónsalud Torrevieja (since 2002)
Clinical Innovations & Special Programs
Personalized Cancer Therapy using RNA microarrays and pharmacogenomics
Autologous Bone Marrow Transplants and High-Dose Chemotherapy
High-Dose Interleukin-2 Therapy via intravenous bolus for solid tumors
Personalized Cellular Anti-Tumor Vaccines
Hyperthermic Isolated Limb Perfusion with TNF and melphalan
Intra-arterial and Intraoperative Chemotherapy (HIPEC) for advanced cancers
Research & Academic Contributions
Author of 120+ scientific papers and conference presentations
Active contributor to the development of novel cancer immunotherapies and drug personalization strategies
Memberships
AACR – American Association for Cancer Research
ASCO – American Society of Clinical Oncology
ASH – American Society of Hematology
- 続きを読む